Kader C. Gedik

Kader C. Gedik

Pediatric Rheumatology
4401 Penn Avenue
Pittsburgh, PA 15224

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications

How I Treat: Haploinsufficiency of A20.

How I Treat: Haploinsufficiency of A20.

Journal: Journal of human immunity
Published: December 13, 2025

The role of epigenetic modifications in systemic autoinflammatory diseases.

The role of epigenetic modifications in systemic autoinflammatory diseases.

Journal: Current opinion in immunology
Published: March 18, 2025

Disease flares with baricitinib dose reductions and development of flare criteria in patients with CANDLE/PRAAS.

Disease flares with baricitinib dose reductions and development of flare criteria in patients with CANDLE/PRAAS.

Journal: Annals of the rheumatic diseases
Published: January 25, 2024

Practical Approach to Diagnosis and Management of IL-1-Mediated Autoinflammatory Diseases (CAPS, TRAPS, MKD, and DIRA).

Practical Approach to Diagnosis and Management of IL-1-Mediated Autoinflammatory Diseases (CAPS, TRAPS, MKD, and DIRA).

Journal: Paediatric drugs
Published: December 11, 2023

The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology points to consider for diagnosis and management of autoinflammatory type I interferonopathies: CANDLE/PRAAS, SAVI and AGS.

The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology points to consider for diagnosis and management of autoinflammatory type I interferonopathies: CANDLE/PRAAS, SAVI and AGS.

Journal: Annals of the rheumatic diseases
Published: November 07, 2021

The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology Points to Consider for Diagnosis and Management of Autoinflammatory Type I Interferonopathies: CANDLE/PRAAS, SAVI, and AGS.

The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology Points to Consider for Diagnosis and Management of Autoinflammatory Type I Interferonopathies: CANDLE/PRAAS, SAVI, and AGS.

Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: November 07, 2021

Rituximab use in pediatric lupus anticoagulant hypoprothrombinemia syndrome - report of three cases and review of the literature.

Rituximab use in pediatric lupus anticoagulant hypoprothrombinemia syndrome - report of three cases and review of the literature.

Journal: Lupus
Published: January 12, 2018
Showing 1-7 of 7

Last Updated: 09/26/2026